Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.
about
Care transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safetyDrivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarinAnticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis.Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study.Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AFAdherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillationImpact of atrial fibrillation on stroke-related healthcare costs.The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort.Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis.Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation.Transitions of care in anticoagulation management for patients with atrial fibrillation.Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.Atrial Fibrillation in Hypertension: Patients' Characteristics.Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
P2860
Q27025527-E94E66A9-55C6-49F4-B1F1-80505B209289Q33553902-34D49E61-8CCB-4CCD-BCEB-AE2D326A0AEAQ33977604-3F0850BD-5A80-46C0-AB34-B0B1E0738DC4Q34020822-FA6DA6F7-7606-4606-BF75-D0FD5AB49223Q34945224-6B96AB41-627A-4F6F-BDDA-31FC384A3F66Q36031425-AA4544EB-9CDF-49E4-9B25-E949AFAD6D25Q37073581-1EEADD42-0195-44CB-A251-E3264193C878Q37153930-E2735793-7E3D-40DA-B864-2EDDEF90F476Q37281384-6EA4178C-AC1F-4F79-827F-87DCBC272917Q37457705-5D47F79B-AAB3-4874-9BD3-FBD4C0E0DF73Q38840977-420E5619-160D-42B7-BD4D-7E1D15FC1492Q38967685-F8FCA31F-9DCC-4550-8D6E-C2D250D68264Q39151928-7816C14C-462C-4DED-AB19-C5D6A83F03D6Q39164366-F79B2936-2A51-41AB-8FAB-D4CF65ECF54CQ40057144-11E9F65F-DBF7-4534-9002-D1980D444B9CQ40186105-F99EDAC8-1191-4CD8-97D7-F3F2FD63F11AQ40304937-B7ACD329-016E-4658-8AA4-3AE142036AFCQ41660727-B83A6A9A-33A4-4752-9697-B9726998B2FCQ41971718-8E2A3A2F-14D8-46FE-8850-7FB49051706AQ51116249-71DFF5EC-DAF4-4627-A2C1-FA23D6586D51Q54966064-B81973F4-7DAC-43B1-A1AE-749272B20806Q57167729-559413DC-27AB-4C84-A08E-FBD6C3AAA0A7
P2860
Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Rates and implications for hos ...... h atrial fibrillation/flutter.
@en
Rates and implications for hos ...... h atrial fibrillation/flutter.
@nl
type
label
Rates and implications for hos ...... h atrial fibrillation/flutter.
@en
Rates and implications for hos ...... h atrial fibrillation/flutter.
@nl
prefLabel
Rates and implications for hos ...... h atrial fibrillation/flutter.
@en
Rates and implications for hos ...... h atrial fibrillation/flutter.
@nl
P2093
P1476
Rates and implications for hos ...... h atrial fibrillation/flutter.
@en
P2093
Gerald V Naccarelli
Mehul Dalal
Parag P Patel
Stephen S Johnston
P304
P356
10.1016/J.AMJCARD.2011.10.009
P407
P577
2011-11-24T00:00:00Z